There was enrichment for PIK3CA mutations in R258G tumours, and PIK3R1 in G356D (log2 odds ratios >2.5), however this failed to reach statistical significance.
← all excerpts
ALK2 inhibitors display beneficial effects in preclinical models of <i>ACVR1</i> mutant diffuse intrinsic pontine glioma.
1
—
—